← Recovery, Skin, Well-Being & EnergyManchester Peptides gold M logo

Manchester Peptides catalogue profile

IGF-1 LR3

A modified, longer-acting analogue of insulin-like growth factor 1 used to investigate IGF-1 receptor signalling. Laboratory research considers cell growth, protein synthesis and metabolic pathways; it is a research reagent rather than an approved medicine.

1 supplied formatNo linked COA displayedResearch reference only
Format illustration · 1 mg · Vial

Available catalogue formats

Choose the listed format

Prices shown are the current catalogue guide prices.

Vial · 1 mg

IGF-1 LR3

£50
Product information

A modified, longer-acting analogue of insulin-like growth factor 1 used to investigate IGF-1 receptor signalling. Laboratory research considers cell growth, protein synthesis and metabolic pathways; it is a research reagent rather than an approved medicine.

Evidence and sources at a glance
Human evidence
There is no established clinical evidence base supporting IGF-1 LR3 as a bodybuilding, recovery or anti-ageing treatment.
Regulatory context
IGF-1 LR3 is a research reagent, not an authorised UK medicine.
Read the full evidence map
PubMed: Long R3 IGF-1 literatureRead the IGF-1 LR3 research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Plain-English identity

What is IGF-1 LR3?

Laboratory work uses it to explore IGF-1 receptor signalling, protein synthesis, cell growth, glucose handling and tissue-development pathways.

Evidence in context

It is a research reagent rather than an approved medicine. Commercial material, biological activity and purity can vary, and claims about bodybuilding or recovery should not be treated as proven clinical outcomes.

Evidence and sources at a glance
Human evidence
There is no established clinical evidence base supporting IGF-1 LR3 as a bodybuilding, recovery or anti-ageing treatment.
Regulatory context
IGF-1 LR3 is a research reagent, not an authorised UK medicine.
Read the full evidence map
Check the independent identity reference: PubMed: Long R3 IGF-1 literature ↗

Third-party documentation

Certificates of Analysis

Reference reports concern the named submitted samples. A catalogue batch match has not been established; check the strength and source on each report.
No product-specific report is currently linked

This should be treated as “not displayed”, not as evidence that analytical verification exists.

Browse all available COAs

Evidence-led research guide

Go deeper into IGF-1 LR3

A laboratory-modified analogue of insulin-like growth factor 1 used to investigate growth-factor signalling.

Read the complete research guide

Last reviewed 10 October 2026. Research and reference information only. This page does not provide dosing instructions, treatment recommendations or medical advice. Not for human or veterinary consumption.